Blog

Sharing Our Expertise

June 2021 - LGM Pharma
The Impact of COVID-19 on Pharma Markets
The pandemic has left a substantial impact on our world that will be felt for years to come. It has led...
Read More >
May 2021 - LGM Pharma
Why a CDMO Might Be the Best Place to Find Regulatory Support
The main goal for any drug company is achieving a speedy path to market. While many obstacles threaten...
Read More >
April 2021 - LGM Pharma
Don’t Ignore the Market Opportunities of Oral Liquid Dosage Forms
Although solid dosage forms like tablets and capsules continue to dominate the global pharmaceutical...
Read More >
March 2021 - LGM Pharma
Reshoring Early-Stage Pharma
The Emergence of a Post COVID-19 Risk Mitigation Strategy Over the last few decades, pharma companies...
Read More >
February 2021 - LGM Pharma
Semi-Solids: Don’t Underestimate the Potential (or the Challenges)
  For decades, the most popular form of drug dosage has consistently remained oral solids —the tablet,...
Read More >
January 2021 - LGM Pharma
2 Key Factors to Accelerate Drug Approvals: Expertise and Relationships
Drug approvals are often complex and time-consuming, even for generic versions of approved medications....
Read More >
1 5 6 7 8 9 10